Notice of revision of consolidated performance forecast
November 2, 2018
Asahi Kasei Corp.
Asahi Kasei Corp.
The consolidated performance forecast for fiscal 2018 (April 1, 2018 – March 31, 2019) announced on May 11, 2018, has been revised as shown below based on recent performance trends.
1． Revision of consolidated forecast
| Net sales (¥ million) |
Operating income (¥ million) |
Ordinary income (¥ million) |
Net income attributable to owners of the parent (¥ million) |
Net income per share (¥) |
|
|---|---|---|---|---|---|
| Previous forecast | 2,155,000 | 190,000 | 199,000 | 140,000 | 100.28 |
| Revised forecast | 2,210,000 | 210,000 | 222,000 | 160,000 | 114.60 |
| Increase | 55,000 | 20,000 | 23,000 | 20,000 | |
| Percent change | +2.6% | +10.5% | +11.6% | +14.3% | |
| cf. fiscal 2017 | 2,042,216 | 198,475 | 212,544 | 170,248 | 121.93 |
2．Reason for revision
Net sales and operating income are now expected to exceed the previous forecast with improved terms of trade for petrochemical products in chemicals operations and increased shipments of defibrillators for professional use in critical care operations. Ordinary income and net income attributable to owners of the parent are now expected to exceed the previous forecast with the higher operating income and increased gain on sales of investment securities.